RVMD
Revolution Medicines, Inc.Company with tickers: RVMD, RVMDW
CIK
1628171
CUSIP
76155X100
Shares Outstanding
212,596,462
Website
https://www.revmed.com
13F Activity (30d)
6 filings
4 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Steve Kelsey, M.D., FRCP, FRCPath | senior advisor to the chief executive officer | Appointed | 2026-06-22 |